Is there a role for infliximab in the treatment of severe ulcerative colitis?: the American experience.
Sandborn
William J
WJ
Inflammatory Bowel Disease Clinic, Division of Gastroenterology & Hepatology, Mayo Clinic, Minnesota, USA.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000473:pathology; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab